Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/21746
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGrigg, Samuel E-
dc.date2019-09-09-
dc.date.accessioned2019-09-16T04:32:24Z-
dc.date.available2019-09-16T04:32:24Z-
dc.date.issued2020-08-
dc.identifier.citationBMJ Evidence-Based Medicine 2020; 25(4): 151-152-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/21746-
dc.language.isoeng-
dc.subjectadult cardiology-
dc.subjectcardiology-
dc.subjectgeneral medicine-
dc.subjectheart failure-
dc.titleAngiotensin- neprilysin inhibitors: should we initiate them in hospital for patients with acute decompensated heart failure?-
dc.typeJournal Article-
dc.identifier.journaltitleBMJ Evidence-Based Medicine-
dc.identifier.affiliationGeneral Medicine-
dc.identifier.doi10.1136/bmjebm-2019-111260-
dc.identifier.orcid0000-0002-6116-6595-
dc.identifier.pubmedid31501222-
dc.type.austinJournal Article-
local.name.researcherGrigg, Samuel E
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
crisitem.author.deptGeneral Medicine-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Mar 2, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.